Counterfeit drug supplier sentenced in UK
A woman who supplied counterfeit prescription drugs to the UK was sentenced to two and a half years at Croydon Crown Court on November 5.
Shazia Amjad was arrested as part of a joint investigation between the Medicines and Healthcare products Regulatory Agency (MHRA) and City of London Police.
Enforcement officers from the MHRA, along with those from City of London Police, found counterfeit prescription drugs worth over L250,000 ($520,225), including more than 50,000 units of ephedrine and a selection of slimming pills, erectile dysfunction pills, painkillers and anabolic steroids, when they searched Ms Amjad's address in November 2006.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze